Search The Medical Knowledge Base

Medical News by Date

• Baxter files subcutaneous HyQ at EMA for Primary Immune Deficiency
  

  Published: Friday 30 September 2011

• FDA approves Soliris for Hemolytic Uremic Syndrome
  

  Published: Thursday 29 September 2011

• EMA concludes Revlimid provides positive treatment for Multiple Myeloma
  

  Published: Thursday 29 September 2011

• FDA supplies approval letter for MelaFind Melanoma imaging system
  

  Published: Thursday 29 September 2011

• Study finds benefits of Xolair for Allergic Asthma treatment
  

  Published: Thursday 29 September 2011

• Daxas shows positive data on "Frequent exacerbations" in COPD
  

  Published: Thursday 29 September 2011

• BOLERO-2 study of Afinitor in ER+HER-2 advanced Breast Cancer is presented at EMCC congress
  

  Published: Thursday 29 September 2011

• GLOW 1 and GLOW 3 studies to support SeebriBreezhaler application.
  

  Published: Wednesday 28 September 2011

• BOLERO-2 study of Afinitor in ER+HER-2 advanced Breast Cancer is presented at EMCC Congress
  

  Published: Wednesday 28 September 2011

• FDA approves Remicade for Pediatric Ulcerative Colitis
  

  Published: Tuesday 27 September 2011

• Zometa reduces risk of Breast Cancer recurrence in post-menopausal patients
  

  Published: Tuesday 27 September 2011

• Xgeva success in Prevention of Bone Metastases in Prostate Cancer
  

  Published: Tuesday 27 September 2011

• Xgeva success in Trial "147" for prevention of bone metastases in Prostate Cancer
  

  Published: Tuesday 27 September 2011

• Alimta maintenance therapy positive in elderly NSCLC patients
  

  Published: Tuesday 27 September 2011

• Optimer Pharma agrees a licence to Cubist Pharma to market Dificid in USA
  

  Published: Monday 26 September 2011

• CHMP recommends Dificlir for Clostrium difficile
  

  Published: Monday 26 September 2011

• CHMP recommends Edarbi/Ipreziv for Hypertension
  

  Published: Monday 26 September 2011

• Xarelto reccommended in Europe for DVT, Stroke and AF
  

  Published: Monday 26 September 2011

• CHMP recommends Onduarp for Hypertension
  

  Published: Monday 26 September 2011

• CHMP recommends Edurant for HIV-1 infection
  

  Published: Monday 26 September 2011

• Imatinib effective in Pulmonary Arterial Hypertension
  

  Published: Monday 26 September 2011

• CHMP recommends Eviplera triple therapy for HIV-1 infection
  

  Published: Monday 26 September 2011

• Decalth PHP brings benefits to patients with Liver Cancer
  

  Published: Monday 26 September 2011

• FDA approves Kombiglyze XR for Type 2 diabetes
  

  Published: Sunday 25 September 2011

• Eliquis launched in UK for VTE
  

  Published: Sunday 25 September 2011

• EU Commission approves Dexdor for sedation of patients in Intensive Care
  

  Published: Sunday 25 September 2011

• Incivo will launch in Germany first for Hepatitis C
  

  Published: Sunday 25 September 2011

• FDA agrees form of CV risk trial for Contrave
  

  Published: Sunday 25 September 2011

• Combination Oladaterol and Tiotropium enters Phase III for COPD
  

  Published: Sunday 25 September 2011

• Viramine XR once a day is EU approved for HIV treatment
  

  Published: Sunday 25 September 2011

• CHMP recommends Komboglyze combination for Type 2 Diabetes
  

  Published: Sunday 25 September 2011

• CHMP recommends triple combination Rasitrio for Hypertension
  

  Published: Sunday 25 September 2011

• Afinitor success in phase III study with angiomyolipomas, associated with Tuberous Sclerosis Complex
  

  Published: Saturday 24 September 2011

• SWIFT MRI assists detection of Oral Cancer
  

  Published: Friday 23 September 2011

• EMA confirms risk benefit of Multaq
  

  Published: Friday 23 September 2011

• New Drug Eluting Stents safer for PCI patients
  

  Published: Thursday 22 September 2011

• Tradjenta shows long term benefits for Type 2 Diabetes patients
  

  Published: Thursday 22 September 2011

• Ostora oral calcitonin safe and effective for Osteoporosis
  

  Published: Thursday 22 September 2011

• QUAD HIV drug more effective than other therapies
  

  Published: Thursday 22 September 2011

• Cellnovo recieves CE mark for Type 1 Diabetes management system
  

  Published: Thursday 22 September 2011

• EMA confirms risk benefit of Multaq
  

  Published: Thursday 22 September 2011

• SHOTZ study shows Forteo more effective than Zometa in bone remodelling
  

  Published: Tuesday 20 September 2011

• New review of Cryoballoon Ablation treatment for Atrial Fibrillation
  

  Published: Monday 19 September 2011

• Galvus achieves significant improvements in Type 2 Diabetes study
  

  Published: Monday 19 September 2011

• Protelos risk benefit profile in PMO questioned
  

  Published: Monday 19 September 2011

• Incivek treatment still effective when course is half as long in treatment of Hepatitis C genotype 1
  

  Published: Monday 19 September 2011

• Vibativ is EU approved for nosocomial pneumonia caused by MNSA
  

  Published: Monday 19 September 2011

• Qnexa to be re-filed at FDA for Obesity
  

  Published: Monday 19 September 2011

• FDA advisors recommend approval of Ferriprox for Iron Overload
  

  Published: Monday 19 September 2011

• Tradjenta shows long term benefits for Type 2 Diabetes patients
  

  Published: Monday 19 September 2011

• Zonegran shows potential for partial Epilepsy in paediatric patients
  

  Published: Saturday 17 September 2011

• Bydureon reduces cardiovascular risk factors in Type 2 Diabetes patients
  

  Published: Saturday 17 September 2011

• TAK 875 a new treatment for Type 2 Diabetes enters Phase III
  

  Published: Saturday 17 September 2011

• IlLLUMINATE trial of Incivek is published in NEJM
  

  Published: Saturday 17 September 2011

• Absorb bioresorbable vascular scaffold in Critical Limb Ischaemia
  

  Published: Saturday 17 September 2011

• ACZ 885 positive in Phase III Juvenile Idiopathic Arthritis trial
  

  Published: Saturday 17 September 2011

• Tradjenta launch for Type 2 Diabetes delayed in Germany
  

  Published: Friday 16 September 2011

• Genentech files vismodegib at FDA for Basal Cell Carcinoma
  

  Published: Friday 16 September 2011

• Provenge sales for Prostate Cancer disappoint Dendreon and lead to staff reduction
  

  Published: Friday 16 September 2011

• Ampio Pharma and Zertane for Premature Ejeculation
  

  Published: Friday 16 September 2011

• New study of Cervarix shows two doses are adequate against HPV types 16 and 18
  

  Published: Friday 16 September 2011

• Tarceva approved in EU as first line treatment against NSCLC with EGFR-mutations
  

  Published: Friday 16 September 2011